Biotech

Anatara Lifesciences Ltd (ASX:ANR) Achieves a Major US FDA Milestone in the Registration of Detach(R) with Approval of the Human Food Safety Dossier

🕔2/5/2018 8:29:16 AM

Anatara Lifesciences (ASX:ANR) has achieved a significant milestone in the United States of America after receiving a "complete" letter from the US Food and Drug Administration for the Technical Section of its Human Food Safety submission. The HFS is a major component of a New Animal Drug Application which is currently underway and is necessary for enabling the marketing of Detach(R) in the US.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Quarterly Activities Report

🕔2/1/2018 8:27:51 AM

Queensland Bauxite Limited (ASX:QBL) provides the Company's Quarterly Activities Report.

Read Full Article

Nanollose Ltd (ASX:NC6) Quarterly Update

🕔1/31/2018 8:21:52 AM

Nanollose Limited (ASX:NC6) is pleased to provide its Appendix 4C Cashflow Statement for the quarter ended 31 December 2017, together with the following operational update.

Read Full Article

Rhinomed Ltd (ASX:RNO) Business Update - December Quarter

🕔1/30/2018 8:55:12 AM

Respiratory technology company Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) can report another strong quarter of growth. During the quarter the company shipped and invoiced $602k ($1.2m for the half year) worth of stock to retailers, consumers and distributors. This reflects the strength of the Company's growing global retail distribution base.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Receives $1.23m R&D Tax Refund

🕔1/18/2018 9:38:13 AM

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $1,230,329 from the Australian Taxation Office under the Federal Government's Research and Development Tax Incentive scheme.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) John Easterling -Amazon John- to Join Board of MCL

🕔1/18/2018 8:55:18 AM

I am delighted and proud on behalf of the Board of Queensland Bauxite Limited (ASX:QBL) to inform our shareholders that Mr John Easterling has agreed to join the board of our Cannabis subsidiary Medical Cannabis Limited.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) MCL Leads in Medical Cannabis with Canadian Deal

🕔1/9/2018 8:30:54 AM

The Board of Queensland Bauxite Ltd (ASX:QBL) is thrilled to be involved in bringing to Australia, through its subsidiary MCL, a fundamentally new product in the world cannabis market, and especially in the Australian market that should be one that will be accepted by the medical industry at large due to the unique benefits and advantages enumerated below.

Read Full Article